Literature DB >> 6161996

The preparation of specific immune sera against type 3 poliovirus D-antigen and C-antigen and the demonstration of two C-antigenic components in vaccine strain populations.

P D Minor, G C Schild, J M Wood, C N Dandawate.   

Abstract

Animals were immunized with purified D-antigen or C-antigen of type 3 poliovirus to produce specific antisera which were used to analyse the antigenic characteristics of the progeny virus in harvests from poliovirus type 3-infected cells. An examination of the virus progeny present at 24 h p.i. of cells with Sabin type 3 vaccine strain virus revealed a large population of particles sedimenting at a slightly lower rate (130S) than infectious virus (155S) in addition to slowly sedimenting (80S) empty capsids. Such 130S particles were not detected in the progeny from cells infected with strains genetically unrelated to the Sabin vaccine strains. They were non-infectious, contained RNA in an RNase-resistant form unless heated, and lacked the virion protein VP4. They expressed C-antigen rather than the D-antigen of infectious virus, and, therefore, had the properties previously described for poliovirus particles eluted from cells. The amount of incorporation of radio-isotope into the proteins or nucleic acids of such particles varied from 15 to 20% to 300% of the amount incorporated into infectious virus depending on the cells and virus strains studied. Virus strains genetically related to Sabin type 3 vaccine virus which were isolated from cases of paralytic poliomyelitis produced the particles in either low or undetectable quantities.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6161996     DOI: 10.1099/0022-1317-51-1-147

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.

Authors:  N A Clarkson; R Kaufman; D M Lublin; T Ward; P A Pipkin; P D Minor; D J Evans; J W Almond
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

2.  Intertypic cross-reactions of nonneutralizing, monoclonal poliovirus antibodies.

Authors:  R Vrijsen; B Rombaut; A Boeye
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

3.  Hybridoma antibodies to poliovirus N and H antigen.

Authors:  P Brioen; R J Sijens; R Vrijsen; B Rombaut; A A Thomas; A Jackers; A Boeyé
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method.

Authors:  T Ward; P A Pipkin; N A Clarkson; D M Stone; P D Minor; J W Almond
Journal:  EMBO J       Date:  1994-11-01       Impact factor: 11.598

5.  Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

Authors:  Chia-Chyi Liu; Meng-Shin Guo; Fion Hsiao-Yu Lin; Kuang-Nan Hsiao; Kate Hsuen-Wen Chang; Ai-Hsiang Chou; Yu-Chao Wang; Yu-Ching Chen; Chung-Shi Yang; Pele Choi-Sing Chong
Journal:  PLoS One       Date:  2011-05-13       Impact factor: 3.240

6.  Immunological and biochemical characterization of coxsackie virus A16 viral particles.

Authors:  Pele Chong; Meng-Shin Guo; Fion Hsiao-Yu Lin; Kuang-Nan Hsiao; Shu-Yang Weng; Ai-Hsiang Chou; Jen-Ren Wang; Shih-Yang Hsieh; Ih-Jen Su; Chia-Chyi Liu
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

7.  Chapter 4 Picornavirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.